Open access
Sep 2026
An acid-responsive nanoagonist delivering chemotherapy-derived tumor antigens to assist cancer immunotherapy
The constructed nanovaccine enhances the proportion of activated dendritic cells in tumor-draining lymph nodes and upregulates tumor-infiltrating T cells while reducing the population of regulatory T cells and other immunosuppressive compartments, echoing the immunoregulatory mechanism of ICIs.
Xing-Yu Zhou, Bo Chen, Ke-Cheng Wu et al.
· Journal of Nanobiotechnology · 0 citations